Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

María‐Victoria Mateos, Hareth Nahi, Wojciech Legieć, Sebastian Grosicki, Vladimir Vorobyev, Ivan Špıčka, Vânia Hungria, Sibirina Korenkova, Nizar J. Bahlis, Max Flogegård, Joan Bladé, Philippe Moreau, Martin Kaiser, Shinsuke Iida, Jacob P. Laubach, Hila Magen, Michèle Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, Pamela L. Clemens, Tara Masterson, Kristen Lantz, Lisa O’Rourke, Christoph Heuck, Xiang Qin, Dolly A. Parasrampuria, Zhilong Yuan, Steven Xu, Ming Qi, Saad Z. Usmani